Paper8969290
Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism.
Kok N and 2 others. Metabolism, 1996. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Papers, record 8969290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8969290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dietary Sucrose | Major topic |
| Fructose | Major topic |
| Liver | Major topic |
| Triglycerides | Major topic |
| Animals | |
| Male | |
| Rats | |
| Rats, Wistar |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39943720 | Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease. | Ann Med | 2025 | https://conductscience.org/library/papers/39943720 | PubMed |
| 35911738 | The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. | Front Immunol | 2022 | https://conductscience.org/library/papers/35911738 | PubMed |
| 34401107 | Assessing the effects of inulin-type fructan intake on body weight, blood glucose, and lipid profile: A systematic review and meta-analysis of randomized controlled trials. | Food Sci Nutr | 2021 | https://conductscience.org/library/papers/34401107 | PubMed |
| 33498781 | Optimization of Porphyran Extraction from Pyropia yezoensis by Response Surface Methodology and Its Lipid-Lowering Effects. | Mar Drugs | 2021 | https://conductscience.org/library/papers/33498781 | PubMed |
| 33440603 | Prebiotic Impacts of Soybean Residue (Okara) on Eubiosis/Dysbiosis Condition of the Gut and the Possible Effects on Liver and Kidney Functions. | Molecules | 2021 | https://conductscience.org/library/papers/33440603 | PubMed |
| 32717871 | Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32717871 | PubMed |
| 31845054 | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. | J Gastroenterol | 2020 | https://conductscience.org/library/papers/31845054 | PubMed |
| 30737251 | Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation. | J Lipid Res | 2019 | https://conductscience.org/library/papers/30737251 | PubMed |
| 30683985 | The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). | Cell Mol Life Sci | 2019 | https://conductscience.org/library/papers/30683985 | PubMed |
| 29693598 | Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine. | Nutrients | 2018 | https://conductscience.org/library/papers/29693598 | PubMed |
| 28713266 | Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/28713266 | PubMed |
| 28425939 | Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. | Nutrients | 2017 | https://conductscience.org/library/papers/28425939 | PubMed |
| 25793679 | Assessment of four experimental models of hyperlipidemia. | Lab Anim (NY) | 2015 | https://conductscience.org/library/papers/25793679 | PubMed |
| 24900346 | Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. | ACS Med Chem Lett | 2011 | https://conductscience.org/library/papers/24900346 | PubMed |
| 24688953 | Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial. | Health Promot Perspect | 2013 | https://conductscience.org/library/papers/24688953 | PubMed |
| 23606109 | Inulin-type fructans with different degrees of polymerization improve lipid metabolism but not glucose metabolism in rats fed a high-fat diet under energy restriction. | Dig Dis Sci | 2013 | https://conductscience.org/library/papers/23606109 | PubMed |
| 23269653 | Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. | Eur J Nutr | 2013 | https://conductscience.org/library/papers/23269653 | PubMed |
| 22187640 | Beta glucan: health benefits in obesity and metabolic syndrome. | J Nutr Metab | 2012 | https://conductscience.org/library/papers/22187640 | PubMed |
| 21695273 | Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. | PLoS One | 2011 | https://conductscience.org/library/papers/21695273 | PubMed |
| 21521255 | Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters. | Clin Endocrinol (Oxf) | 2011 | https://conductscience.org/library/papers/21521255 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8969290
GET https://conductscience.org/api/papers/v1/8969290/cited_by?page=2